US20060227513A1 - Controlling biological fluids in microelectromechanical machines - Google Patents
Controlling biological fluids in microelectromechanical machines Download PDFInfo
- Publication number
- US20060227513A1 US20060227513A1 US11/153,788 US15378805A US2006227513A1 US 20060227513 A1 US20060227513 A1 US 20060227513A1 US 15378805 A US15378805 A US 15378805A US 2006227513 A1 US2006227513 A1 US 2006227513A1
- Authority
- US
- United States
- Prior art keywords
- valve
- bioactive material
- polymer layer
- inert particles
- substrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L23/00—Details of semiconductor or other solid state devices
- H01L23/34—Arrangements for cooling, heating, ventilating or temperature compensation ; Temperature sensing arrangements
- H01L23/46—Arrangements for cooling, heating, ventilating or temperature compensation ; Temperature sensing arrangements involving the transfer of heat by flowing fluids
- H01L23/473—Arrangements for cooling, heating, ventilating or temperature compensation ; Temperature sensing arrangements involving the transfer of heat by flowing fluids by flowing liquids
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F28—HEAT EXCHANGE IN GENERAL
- F28F—DETAILS OF HEAT-EXCHANGE AND HEAT-TRANSFER APPARATUS, OF GENERAL APPLICATION
- F28F19/00—Preventing the formation of deposits or corrosion, e.g. by using filters or scrapers
- F28F19/002—Preventing the formation of deposits or corrosion, e.g. by using filters or scrapers by using inserts or attachments
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F28—HEAT EXCHANGE IN GENERAL
- F28F—DETAILS OF HEAT-EXCHANGE AND HEAT-TRANSFER APPARATUS, OF GENERAL APPLICATION
- F28F27/00—Control arrangements or safety devices specially adapted for heat-exchange or heat-transfer apparatus
- F28F27/02—Control arrangements or safety devices specially adapted for heat-exchange or heat-transfer apparatus for controlling the distribution of heat-exchange media between different channels
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F28—HEAT EXCHANGE IN GENERAL
- F28F—DETAILS OF HEAT-EXCHANGE AND HEAT-TRANSFER APPARATUS, OF GENERAL APPLICATION
- F28F3/00—Plate-like or laminated elements; Assemblies of plate-like or laminated elements
- F28F3/12—Elements constructed in the shape of a hollow panel, e.g. with channels
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F28—HEAT EXCHANGE IN GENERAL
- F28F—DETAILS OF HEAT-EXCHANGE AND HEAT-TRANSFER APPARATUS, OF GENERAL APPLICATION
- F28F2255/00—Heat exchanger elements made of materials having special features or resulting from particular manufacturing processes
- F28F2255/04—Heat exchanger elements made of materials having special features or resulting from particular manufacturing processes comprising shape memory alloys or bimetallic elements
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L2924/00—Indexing scheme for arrangements or methods for connecting or disconnecting semiconductor or solid-state bodies as covered by H01L24/00
- H01L2924/0001—Technical content checked by a classifier
- H01L2924/0002—Not covered by any one of groups H01L24/00, H01L24/00 and H01L2224/00
Definitions
- This invention relates generally to microelectromechanical systems used in biological applications.
- microelectronic machines may be provided within external apparatus for the control of patient treatment.
- microelectronic mechanical systems may be sufficiently small that they may be implanted in situ to provide patient treatment.
- FIG. 1 is a greatly enlarged, cross-sectional view in accordance with one embodiment of the present invention
- FIG. 2 is a greatly enlarged, cross-sectional view taken generally along the line 2 - 2 in FIG. 1 in accordance with one embodiment of the present invention
- FIG. 3 is a cross-sectional view corresponding to FIG. 1 in use in accordance with one embodiment of the present invention
- FIG. 4 is a cross-sectional view taken generally along the line 4 - 4 in FIG. 1 in accordance with one embodiment of the present invention
- FIG. 5 is a cross-sectional view taken generally along the line 5 - 5 in FIG. 1 in accordance with one embodiment of the present invention
- FIG. 6 is an enlarged, cross-sectional view corresponding to FIG. 1 at an early stage of manufacture in accordance with one embodiment of the present invention
- FIG. 7 is an enlarged, cross-sectional view corresponding to FIG. 6 at a subsequent stage of manufacture in accordance with one embodiment of the present invention.
- FIG. 8 is an enlarged, cross-sectional view corresponding to FIG. 7 at a subsequent stage of manufacture in accordance with one embodiment of the present invention.
- an apparatus 10 may be implanted within a patient or may be external to the patient.
- Fluid indicated as A
- the flow of fluid A may be a flow of blood which is to be treated with appropriate therapeutic agents.
- the therapeutic agents, indicated as B may flow from the passage 14 a under control of a microelectromechanical system (MEMS) leaf valve 16 .
- MEMS microelectromechanical system
- the valve 16 controls the flow of fluid B from the channel 14 a into the channel 14 b and thereby regulates the therapeutic treatment.
- the apparatus 10 may be made in two parts, including an upper part 12 b and a lower part 12 a .
- the two parts 12 may be permanently joined along the junction surface 12 c in one embodiment of the present invention.
- the part 12 b may have a passage 14 a formed therein to allow the passage of the fluid B while the part 12 a may have the passage 14 b formed in it.
- the parts 12 a and 12 b may be fabricated using semiconductor fabrication techniques in some embodiments of the present invention.
- the passages 14 b and 14 a may be formed by conventional lithographic techniques in one embodiment.
- a leaf valve 16 includes a first portion 16 a secured to the part 12 b and a second portion 16 b cantilevered over the passage 14 a in the part 12 a . Also formed on the surface 12 c and, particularly, in one embodiment, the outside surface of the part 12 b , are a plurality of roughenings or fluidic trips 18 . At least some of the trips 18 may be located on the surface 12 c proximate to the passage 14 a.
- the trips 18 function to create turbulent flow at the interface between the passages 14 a and 14 b .
- the turbulent fluidic flow assists in mixing the two fluids A and B.
- the flow of biological fluid to be treated, indicated at A may be treated with the liquid, indicated at B, through a mixing action facilitated by the trips 18 , especially when the valve 16 is opened.
- the valve 16 may be formed of a flexible, multilayer structure.
- the lowest layer may include aluminum covered by copper 22 .
- the layers 24 and 22 have different coefficients of thermal expansion in some embodiments and, therefore, may bend in controllable ways in response to heating.
- the makeup of layers 22 and 24 may be similar to that used in switches for thermostat control.
- a polymer layer 20 having formed therein with a coated inert particles such as glass beads 26 .
- a coated inert particles such as glass beads 26 .
- Some of the glass beads 26 extend out of the surface of the layer 20 , as indicated at 26 a , and others are intermeshed within the polymer as indicated at 26 b .
- the glass beads 26 may function as carriers for biological agents. Structures other than glass beads may also be used.
- the glass beads 26 may be coated with an appropriate functionalizing material which, in one embodiment, includes reactive components, such as free radicals, to react with passing molecules.
- the glass beads 26 functionalized with a protein streptavidin may be coated with a layer including deoxyribonucleic acid (DNA).
- the glass beads 26 a may be coated with an appropriate material having free reactive radicals to react with passing molecules. In one embodiment, this means that materials in the blood, passing through the passage 14 b , may react and adhere to the exposed glass beads 26 a .
- the glass beads 26 may be considered bioactive glass beads which are receptive to bio-agents, such as proteins, which attach to the free radicals on the glass beads 26 a i n one embodiment. “Bioactive” encompasses any material that may have an effect on any living tissue.
- an in vitro delivery of medication may be made to blood passing through the apparatus 10 , passage 14 a .
- a species within the passing blood may react with the bioactive glass beads 26 a that are exposed on the valve 16 .
- the reactive constituents adhere to the glass beads 26 a and more, particularly, to a reactive coating on the beads 26 c.
- the reactive constituents in the blood collect on the surface of the valve 16 as indicated at C.
- the weight of these constituents pulls the valve 16 open by hingedly rotating the valve portion 16 b in a cantilevered fashion downwardly and away from the passage 14 a , still secured at portion 16 a , to the part 12 b .
- turbulent flow is generated, as indicated by the arrows D, facilitating the mixing of the fluid B in the passage 14 a with the fluid A in the passage 14 b.
- the passage 14 a in one embodiment, may be a circular portion 14 e that includes a connecting portion 14 d which connects to a source of therapeutic agent. Proximate to the downstream edge of the passage 14 a may be the fluidic trips 18 . In some embodiments, the fluidic trips 18 may cover the entire exposed surface 12 c of the portion 12 b.
- the part 12 a may include the passage 14 b formed therein.
- the passage 14 b may be a trench aligned with the circular portion 14 e of the passage 14 a.
- the apparatus 10 may be fabricated in an inverted fashion beginning in FIG. 6 .
- a substrate, forming the part 12 b may have a passage 14 a formed therein.
- the passage 14 a may be filled with a material 30 which may be relatively easily removed, for example, by exposure to heat.
- a layer that will form the valve 16 Over the material 30 and the part 12 b may be deposited a layer that will form the valve 16 .
- the layer that will form the valve 16 is then patterned and etched to form the portion 16 a adhered to the part 12 b and the portion 16 b which, at this point, is still adhered to the material 30 that fills the passage 14 a.
- the trips 18 may be formed as incompletely removed portions of the layer that forms the valve 16 .
- the trips 18 which may be surface roughenings, may extend across the upper exposed surface 12 c of the part 12 b at the stage shown in FIG. 7 .
- a coating (not shown) may be applied thereover which is sufficiently rough to form the trips 18 .
- that coating may be partially removed by etching, leaving residue which acts as the trips 18 .
- the material 30 may be removed by conventional techniques including the application of heat and the removal by decomposition of the material 30 .
- An example of such a material is a polymer such as polycarbonate and polynorbornene.
- This forms the open passage 14 a better shown in FIG. 4 .
- This removal also frees the free cantilevered end portion 16 b of the valve 16 to be movable into the passage 14 b .
- the two parts 12 b and 12 a may be secured together using adhesive or other techniques.
- the passage 14 b can receive fluids, indicated as A, and mix into those fluids, the fluid B in the passage 14 a.
- the reaction between the treatment agent and the biological fluid may be controlled on an as needed basis.
- that amount of therapeutic agent may be provided which is actually needed.
- the body is free from being exposed to excessive concentrations of the treatment agents in some embodiments.
- under-treatment may be reduced as well in some embodiments.
- just the right amount of therapeutic agents may be provided.
Abstract
A therapeutic agent may be dispensed into a biological fluid on an as needed basis. A microelectromechanical system valve may dispense the therapeutic agent as needed. The valve may sense the extent of the need for the therapeutic agent and may controllably open to provide that therapeutic agent in response thereto.
Description
- This application is a continuation-in-part of U.S. application Ser. No. 11/103,216, filed Apr. 11, 2005.
- This invention relates generally to microelectromechanical systems used in biological applications.
- Semiconductor fabricated machines of extremely small dimensions have potential medical applications. For example, microelectronic machines may be provided within external apparatus for the control of patient treatment. In addition, microelectronic mechanical systems may be sufficiently small that they may be implanted in situ to provide patient treatment.
-
FIG. 1 is a greatly enlarged, cross-sectional view in accordance with one embodiment of the present invention; -
FIG. 2 is a greatly enlarged, cross-sectional view taken generally along the line 2-2 inFIG. 1 in accordance with one embodiment of the present invention; -
FIG. 3 is a cross-sectional view corresponding toFIG. 1 in use in accordance with one embodiment of the present invention; -
FIG. 4 is a cross-sectional view taken generally along the line 4-4 inFIG. 1 in accordance with one embodiment of the present invention; -
FIG. 5 is a cross-sectional view taken generally along the line 5-5 inFIG. 1 in accordance with one embodiment of the present invention; -
FIG. 6 is an enlarged, cross-sectional view corresponding toFIG. 1 at an early stage of manufacture in accordance with one embodiment of the present invention; -
FIG. 7 is an enlarged, cross-sectional view corresponding toFIG. 6 at a subsequent stage of manufacture in accordance with one embodiment of the present invention; and -
FIG. 8 is an enlarged, cross-sectional view corresponding toFIG. 7 at a subsequent stage of manufacture in accordance with one embodiment of the present invention. - Referring to
FIG. 1 , anapparatus 10 may be implanted within a patient or may be external to the patient. Fluid, indicated as A, may flow in and through thedevice 10. For example, the flow of fluid A may be a flow of blood which is to be treated with appropriate therapeutic agents. The therapeutic agents, indicated as B, may flow from thepassage 14 a under control of a microelectromechanical system (MEMS)leaf valve 16. In other words, thevalve 16 controls the flow of fluid B from thechannel 14 a into thechannel 14 b and thereby regulates the therapeutic treatment. - In one embodiment, the
apparatus 10 may be made in two parts, including anupper part 12 b and alower part 12 a. The two parts 12 may be permanently joined along thejunction surface 12 c in one embodiment of the present invention. Thus, thepart 12 b may have apassage 14 a formed therein to allow the passage of the fluid B while thepart 12 a may have thepassage 14 b formed in it. Theparts passages - Controlling the communication between the
passages leaf valve 16 includes afirst portion 16 a secured to thepart 12 b and asecond portion 16 b cantilevered over thepassage 14 a in thepart 12 a. Also formed on thesurface 12 c and, particularly, in one embodiment, the outside surface of thepart 12 b, are a plurality of roughenings orfluidic trips 18. At least some of thetrips 18 may be located on thesurface 12 c proximate to thepassage 14 a. - The
trips 18 function to create turbulent flow at the interface between thepassages trips 18, especially when thevalve 16 is opened. - The
valve 16 may be formed of a flexible, multilayer structure. The lowest layer may include aluminum covered bycopper 22. Thelayers layers - Over the
layer 22 may be situated apolymer layer 20 having formed therein with a coated inert particles such as glass beads 26. Some of the glass beads 26 extend out of the surface of thelayer 20, as indicated at 26 a, and others are intermeshed within the polymer as indicated at 26 b. The glass beads 26 may function as carriers for biological agents. Structures other than glass beads may also be used. - The glass beads 26 may be coated with an appropriate functionalizing material which, in one embodiment, includes reactive components, such as free radicals, to react with passing molecules. For example, the glass beads 26 functionalized with a protein streptavidin may be coated with a layer including deoxyribonucleic acid (DNA). In other words, the
glass beads 26 a may be coated with an appropriate material having free reactive radicals to react with passing molecules. In one embodiment, this means that materials in the blood, passing through thepassage 14 b, may react and adhere to the exposedglass beads 26 a. The glass beads 26 may be considered bioactive glass beads which are receptive to bio-agents, such as proteins, which attach to the free radicals on theglass beads 26 a i n one embodiment. “Bioactive” encompasses any material that may have an effect on any living tissue. - As one application, an in vitro delivery of medication may be made to blood passing through the
apparatus 10,passage 14 a. A species within the passing blood may react with thebioactive glass beads 26 a that are exposed on thevalve 16. The reactive constituents adhere to theglass beads 26 a and more, particularly, to a reactive coating on the beads 26 c. - Thus, in one embodiment, shown in
FIG. 3 , the reactive constituents in the blood collect on the surface of thevalve 16 as indicated at C. The weight of these constituents pulls thevalve 16 open by hingedly rotating thevalve portion 16 b in a cantilevered fashion downwardly and away from thepassage 14 a, still secured atportion 16 a, to thepart 12 b. As shown inFIG. 3 , as a result of the action of thefluidic trips 18, turbulent flow is generated, as indicated by the arrows D, facilitating the mixing of the fluid B in thepassage 14 a with the fluid A in thepassage 14 b. - Referring to
FIG. 4 , thepassage 14 a, in one embodiment, may be acircular portion 14 e that includes a connectingportion 14 d which connects to a source of therapeutic agent. Proximate to the downstream edge of thepassage 14 a may be thefluidic trips 18. In some embodiments, thefluidic trips 18 may cover the entire exposedsurface 12 c of theportion 12 b. - Referring to
FIG. 5 , thepart 12 a may include thepassage 14 b formed therein. Thepassage 14 b may be a trench aligned with thecircular portion 14 e of thepassage 14 a. - Referring to
FIGS. 6-8 , in accordance with one embodiment of the present invention, theapparatus 10 may be fabricated in an inverted fashion beginning inFIG. 6 . There, a substrate, forming thepart 12 b, may have apassage 14 a formed therein. Thepassage 14 a may be filled with amaterial 30 which may be relatively easily removed, for example, by exposure to heat. - Over the
material 30 and thepart 12 b may be deposited a layer that will form thevalve 16. The layer that will form thevalve 16 is then patterned and etched to form theportion 16 a adhered to thepart 12 b and theportion 16 b which, at this point, is still adhered to thematerial 30 that fills thepassage 14 a. - In one embodiment, the
trips 18 may be formed as incompletely removed portions of the layer that forms thevalve 16. In such case, thetrips 18, which may be surface roughenings, may extend across the upper exposedsurface 12 c of thepart 12 b at the stage shown inFIG. 7 . In other embodiments, after etching and defining thevalve 16, a coating (not shown) may be applied thereover which is sufficiently rough to form thetrips 18. In still another embodiment, that coating may be partially removed by etching, leaving residue which acts as thetrips 18. - Then, as shown in
FIG. 8 , thematerial 30 may be removed by conventional techniques including the application of heat and the removal by decomposition of thematerial 30. An example of such a material is a polymer such as polycarbonate and polynorbornene. This forms theopen passage 14 a, better shown inFIG. 4 . This removal also frees the freecantilevered end portion 16 b of thevalve 16 to be movable into thepassage 14 b. Then, the twoparts passage 14 b can receive fluids, indicated as A, and mix into those fluids, the fluid B in thepassage 14 a. - In some embodiments, the reaction between the treatment agent and the biological fluid may be controlled on an as needed basis. In other words, instead of simply flooding the body with extra treatment agents, such as drugs, that amount of therapeutic agent may be provided which is actually needed. As a result, the body is free from being exposed to excessive concentrations of the treatment agents in some embodiments. In addition, under-treatment may be reduced as well in some embodiments. Thus, in some embodiments, just the right amount of therapeutic agents may be provided.
- While the present invention has been described with respect to a limited number of embodiments, those skilled in the art will appreciate numerous modifications and variations therefrom. It is intended that the appended claims cover all such modifications and variations as fall within the true spirit and scope of this present invention.
Claims (27)
1. A method comprising:
providing a microelectromechanical system valve to sense the need to dispense a therapeutic agent.
2. The method of claim 1 including forming a microelectromechanical system valve in the form of a leaf valve.
3. The method of claim 2 including forming a depression in a first substrate and forming said valve over said depression.
4. The method of claim 3 including forming a trench through a second substrate and securing said first substrate and said second substrate together.
5. The method of claim 1 including providing fluidic trips to form turbulent flow proximate to said valve to mix fluid controlled by said valve.
6. The method of claim 5 including forming said valve with a bioactive material.
7. The method of claim 6 including forming a bimetal valve.
8. The method of claim 6 including forming a polymer layer on said valve, said polymer layer including inert particles.
9. The method of claim 8 including functionalizing said inert particles.
10. The method of claim 9 including arranging said valve to be actuated in response to a chemical reaction with material on said inert particles.
11. A dispensing device comprising:
a first flow passage;
a second flow passage; and
a microelectromechanical system valve to control the flow of fluid from one passage to the other, said system including fluidic trips to cause turbulent flow and mixing the fluids from said first and second flow passages.
12. The device of claim 11 wherein said valve is a leaf valve.
13. The device of claim 12 including a pair of substrates, said first flow passage formed in one substrate and said second flow passage formed in the other substrate and said valve formed between said substrates.
14. The device of claim 11 wherein said valve includes a bioactive material.
15. The device of claim 11 wherein said valve is a bimetal valve.
16. The device of claim 15 wherein said valve includes a bioactive material.
17. The device of claim 14 including a polymer layer and said bioactive material is embedded in said polymer layer.
18. The device of claim 17 including inert particles embedded in said polymer layer, said inert particles including a reactive material coated on said particles.
19. The device of claim 14 wherein said valve is operable in response to the extent of reactions with said bioactive material.
20. An apparatus comprising:
a pair of passages;
a valve to selectively control the extent of communication between said passages, said valve including a bioactive material, said valve operable in response to chemical reactions with said bioactive material.
21. The apparatus of claim 20 wherein said valve is a leaf valve.
22. The apparatus of claim 20 wherein said valve is a microelectromechanical system valve.
23. The apparatus of claim 20 wherein said valve includes a layer having a coating of bioactive material.
24. The apparatus of claim 23 wherein said layer includes inert particles having a bioactive coating thereon.
25. The apparatus of claim 24 wherein said inert particles are in the form of glass beads.
26. The apparatus of claim 25 including a polymer layer and wherein said glass beads are embedded in said polymer layer.
27. The apparatus of claim 20 wherein reactions with said bioactive material open said valve when sufficient accumulation occurs on said valve to pull said valve open.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/153,788 US20060227513A1 (en) | 2005-04-11 | 2005-06-15 | Controlling biological fluids in microelectromechanical machines |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/103,216 US7652372B2 (en) | 2005-04-11 | 2005-04-11 | Microfluidic cooling of integrated circuits |
US11/153,788 US20060227513A1 (en) | 2005-04-11 | 2005-06-15 | Controlling biological fluids in microelectromechanical machines |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/103,216 Continuation-In-Part US7652372B2 (en) | 2005-04-11 | 2005-04-11 | Microfluidic cooling of integrated circuits |
Publications (1)
Publication Number | Publication Date |
---|---|
US20060227513A1 true US20060227513A1 (en) | 2006-10-12 |
Family
ID=37082939
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/103,216 Expired - Fee Related US7652372B2 (en) | 2005-04-11 | 2005-04-11 | Microfluidic cooling of integrated circuits |
US11/153,788 Abandoned US20060227513A1 (en) | 2005-04-11 | 2005-06-15 | Controlling biological fluids in microelectromechanical machines |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/103,216 Expired - Fee Related US7652372B2 (en) | 2005-04-11 | 2005-04-11 | Microfluidic cooling of integrated circuits |
Country Status (5)
Country | Link |
---|---|
US (2) | US7652372B2 (en) |
EP (1) | EP1869703A1 (en) |
JP (1) | JP4966962B2 (en) |
TW (1) | TWI298937B (en) |
WO (1) | WO2006110903A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11931741B2 (en) | 2019-03-06 | 2024-03-19 | Princeton Biochemicals, Inc | Uniformly pressing micro-valve system for controlling path of fluids in miniaturized capillary connections and methods of fabrication |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070113907A1 (en) * | 2005-11-18 | 2007-05-24 | Reid Brennen | Devices and methods using fluid-transporting features of differing dwell times |
WO2010117874A2 (en) * | 2009-04-05 | 2010-10-14 | Microstaq, Inc. | Method and structure for optimizing heat exchanger performance |
TWI410617B (en) * | 2009-12-28 | 2013-10-01 | Univ Feng Chia | Air Control Microflow Detection Device |
CN101906378A (en) * | 2010-07-05 | 2010-12-08 | 博奥生物有限公司 | Bubble micro valve and bubble micro valve-based micro-fluidic chip |
DE102011100706A1 (en) * | 2011-05-06 | 2012-11-08 | GM Global Technology Operations LLC (n. d. Gesetzen des Staates Delaware) | Adjustable heat exchanger for a motor vehicle air conditioning system |
US9219022B2 (en) | 2012-03-08 | 2015-12-22 | International Business Machines Corporation | Cold plate with combined inclined impingement and ribbed channels |
CN103087915B (en) * | 2013-01-10 | 2015-04-22 | 中国科学院深圳先进技术研究院 | Bubble eliminating device for high-throughput microfluidics cell chip and operation method thereof |
JP5534067B1 (en) * | 2013-03-06 | 2014-06-25 | 日本電気株式会社 | Electronic component and electronic component cooling method |
US9510478B2 (en) | 2013-06-20 | 2016-11-29 | Honeywell International Inc. | Cooling device including etched lateral microchannels |
FR3010830B1 (en) * | 2013-09-17 | 2016-12-23 | Commissariat Energie Atomique | DEVICE FOR COOLING AN INTEGRATED CIRCUIT CHIP |
CN103824826B (en) * | 2014-02-21 | 2017-01-04 | 电子科技大学 | A kind of fluid channel heat dissipating method |
US10317962B2 (en) | 2016-08-16 | 2019-06-11 | International Business Machines Corporation | Inducing heterogeneous microprocessor behavior using non-uniform cooling |
US10558249B2 (en) | 2016-09-27 | 2020-02-11 | International Business Machines Corporation | Sensor-based non-uniform cooling |
CN111405818B (en) * | 2020-03-25 | 2021-08-06 | 电子科技大学 | Micro-channel self-adaptive cooling system integrated with temperature sensor |
US11876036B2 (en) | 2020-06-18 | 2024-01-16 | The Research Foundation For The State University Of New York | Fluid cooling system including embedded channels and cold plates |
US11956931B2 (en) | 2021-02-18 | 2024-04-09 | Nvidia Corporation | Intelligent and dynamic cold plate for datacenter cooling systems |
CN113028858A (en) * | 2021-03-23 | 2021-06-25 | 中国航发沈阳发动机研究所 | Self-adaptive heat exchanger based on memory alloy |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5316077A (en) * | 1992-12-09 | 1994-05-31 | Eaton Corporation | Heat sink for electrical circuit components |
US5441597A (en) * | 1992-12-01 | 1995-08-15 | Honeywell Inc. | Microstructure gas valve control forming method |
US5535818A (en) * | 1992-10-12 | 1996-07-16 | Fujitsu Limited | Cooling system for electronic device |
US20020068295A1 (en) * | 2000-07-13 | 2002-06-06 | Marc Madou | Multimeric biopolymers as structural elements and sensors and actuators in microsystems |
US6406260B1 (en) * | 1999-10-22 | 2002-06-18 | Pratt & Whitney Canada Corp. | Heat transfer promotion structure for internally convectively cooled airfoils |
US20030124627A1 (en) * | 2001-11-29 | 2003-07-03 | Burmer Glenna C. | Diagnostic and therapeutic compositions and methods related to chemokine (C motif ) XC receptor 1 (CCXCR1), a G protein-coupled receptor (GPCR) |
US6590267B1 (en) * | 2000-09-14 | 2003-07-08 | Mcnc | Microelectromechanical flexible membrane electrostatic valve device and related fabrication methods |
US7544207B2 (en) * | 2004-10-06 | 2009-06-09 | Cook Incorporated | Medical device with bioactive agent |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4022240A (en) * | 1974-08-22 | 1977-05-10 | The Perkin-Elmer Corporation | Slide valve sealant system |
US4989070A (en) * | 1988-11-10 | 1991-01-29 | Coriolis Corporation | Modular heat sink structure |
US6227809B1 (en) * | 1995-03-09 | 2001-05-08 | University Of Washington | Method for making micropumps |
US7015047B2 (en) * | 2001-01-26 | 2006-03-21 | Aviva Biosciences Corporation | Microdevices having a preferential axis of magnetization and uses thereof |
US6520477B2 (en) * | 2001-02-01 | 2003-02-18 | William Trimmer | Micro pump |
CA2456171C (en) * | 2001-08-01 | 2010-10-12 | Voyant Technologies, Inc. | Local exchange subscriber line conferencing method |
US7025323B2 (en) * | 2001-09-21 | 2006-04-11 | The Regents Of The University Of California | Low power integrated pumping and valving arrays for microfluidic systems |
US6942018B2 (en) * | 2001-09-28 | 2005-09-13 | The Board Of Trustees Of The Leland Stanford Junior University | Electroosmotic microchannel cooling system |
US6877528B2 (en) * | 2002-04-17 | 2005-04-12 | Cytonome, Inc. | Microfluidic system including a bubble valve for regulating fluid flow through a microchannel |
TWI234063B (en) * | 2002-05-15 | 2005-06-11 | Matsushita Electric Ind Co Ltd | Cooling apparatus for electronic equipment |
JP2003336949A (en) * | 2002-05-17 | 2003-11-28 | Yamatake Corp | Refrigerant moving device and cooling device |
US6679279B1 (en) * | 2002-07-10 | 2004-01-20 | Motorola, Inc. | Fluidic valve having a bi-phase valve element |
US7338637B2 (en) * | 2003-01-31 | 2008-03-04 | Hewlett-Packard Development Company, L.P. | Microfluidic device with thin-film electronic devices |
JP2004289049A (en) | 2003-03-25 | 2004-10-14 | Seiko Instruments Inc | Heat transport device and portable electronic equipment with the device |
JP2004295718A (en) * | 2003-03-28 | 2004-10-21 | Hitachi Ltd | Liquid cooling system for information processor |
-
2005
- 2005-04-11 US US11/103,216 patent/US7652372B2/en not_active Expired - Fee Related
- 2005-06-15 US US11/153,788 patent/US20060227513A1/en not_active Abandoned
-
2006
- 2006-04-10 TW TW095112703A patent/TWI298937B/en not_active IP Right Cessation
- 2006-04-11 EP EP06750238A patent/EP1869703A1/en not_active Withdrawn
- 2006-04-11 JP JP2008506762A patent/JP4966962B2/en not_active Expired - Fee Related
- 2006-04-11 WO PCT/US2006/014148 patent/WO2006110903A1/en active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5535818A (en) * | 1992-10-12 | 1996-07-16 | Fujitsu Limited | Cooling system for electronic device |
US5441597A (en) * | 1992-12-01 | 1995-08-15 | Honeywell Inc. | Microstructure gas valve control forming method |
US5316077A (en) * | 1992-12-09 | 1994-05-31 | Eaton Corporation | Heat sink for electrical circuit components |
US6406260B1 (en) * | 1999-10-22 | 2002-06-18 | Pratt & Whitney Canada Corp. | Heat transfer promotion structure for internally convectively cooled airfoils |
US20020068295A1 (en) * | 2000-07-13 | 2002-06-06 | Marc Madou | Multimeric biopolymers as structural elements and sensors and actuators in microsystems |
US6590267B1 (en) * | 2000-09-14 | 2003-07-08 | Mcnc | Microelectromechanical flexible membrane electrostatic valve device and related fabrication methods |
US20030124627A1 (en) * | 2001-11-29 | 2003-07-03 | Burmer Glenna C. | Diagnostic and therapeutic compositions and methods related to chemokine (C motif ) XC receptor 1 (CCXCR1), a G protein-coupled receptor (GPCR) |
US7544207B2 (en) * | 2004-10-06 | 2009-06-09 | Cook Incorporated | Medical device with bioactive agent |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11931741B2 (en) | 2019-03-06 | 2024-03-19 | Princeton Biochemicals, Inc | Uniformly pressing micro-valve system for controlling path of fluids in miniaturized capillary connections and methods of fabrication |
Also Published As
Publication number | Publication date |
---|---|
US7652372B2 (en) | 2010-01-26 |
TWI298937B (en) | 2008-07-11 |
JP4966962B2 (en) | 2012-07-04 |
EP1869703A1 (en) | 2007-12-26 |
US20060227512A1 (en) | 2006-10-12 |
TW200636955A (en) | 2006-10-16 |
WO2006110903A1 (en) | 2006-10-19 |
JP2008536337A (en) | 2008-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060227513A1 (en) | Controlling biological fluids in microelectromechanical machines | |
US8915957B2 (en) | Drug delivery stent | |
TWI245739B (en) | Method and device for flowing a liquid on a surface | |
CN103826690B (en) | Micro-fluidic drug delivery device | |
US8039205B2 (en) | Fluidic MEMS device | |
Polla et al. | Microdevices in medicine | |
US7232109B2 (en) | Electrostatic valves for microfluidic devices | |
WO2007064117A1 (en) | Affinity chromatography microdevice and method for manufacturing the same | |
JP4658130B2 (en) | Decal transfer lithography | |
JP4157134B2 (en) | Reagent container, slide reaction tray and holding tray, and method of operation | |
US7238324B2 (en) | Microfluidic device for the controlled movement of fluid | |
US20120181460A1 (en) | Valves with Hydraulic Actuation System | |
US20110117582A1 (en) | Multi-biomarker biosensor | |
JP5678272B2 (en) | Channel structure and manufacturing method thereof | |
ES2263400B1 (en) | FLEXIBLE MICRO-NANOFLUIDIC DEVICES. | |
JP2001509727A (en) | Liquid distribution system | |
JP2003534538A (en) | Microfluidic system including three-dimensional array channel network | |
KR20040100245A (en) | Micro-fluidic device to control flow time of micro-fluid | |
JP2005114430A (en) | Method for manipulating trace amount of liquid, method for crystallizing protein using the same, and apparatus for manipulating trace amount of liquid | |
JP2004000163A (en) | Cell used for treating cell | |
CN100451737C (en) | Flexible electrostatic actuator | |
US10722696B2 (en) | Nano-scale coatings and related methods suitable for in-vivo use | |
US20080286153A1 (en) | Affinity Chromatography Microdevice and Method for Manufacturing the Same | |
US20090099553A1 (en) | Device for the controlled release of a substance and method of releasing a substance | |
JP2020527411A (en) | Liquid delivery device and method of delivering liquid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: INTEL CORPORATION, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DISHONGH, TERRY J.;CASSEZZA, JASON T.;RHODES, KEVIN S.;AND OTHERS;REEL/FRAME:016699/0518 Effective date: 20050603 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |